We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$312M
AUM Growth
+$21.3M
Cap. Flow
+$9.21M
Cap. Flow %
2.95%
Top 10 Hldgs %
56.55%
Holding
35
New
5
Increased
15
Reduced
12
Closed
2

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$5.28M
2
ELV icon
Elevance Health
ELV
+$4.62M
3
BMY icon
Bristol-Myers Squibb
BMY
+$4.01M
4
AMGN icon
Amgen
AMGN
+$3.84M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.13M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$10.3M
2
PFE icon
Pfizer
PFE
+$6.02M
3
GILD icon
Gilead Sciences
GILD
+$5.93M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.38M
5
INCY icon
Incyte
INCY
+$2.68M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$26.5M 8.5%
435,000
+68,834
+19% +$4.01M
PFE icon
2
Pfizer
PFE
$143B
$23.4M 7.51%
925,000
-230,000
-20% -$6.02M
BDX icon
3
Becton Dickinson
BDX
$43.6B
$18.8M 6.02%
82,000
+6,000
+8% +$1.39M
MDT icon
4
Medtronic
MDT
$106B
$18.4M 5.9%
205,000
-115,000
-36% -$10.3M
AMGN icon
5
Amgen
AMGN
$198B
$18.4M 5.89%
59,000
+13,000
+28% +$3.84M
JNJ icon
6
Johnson & Johnson
JNJ
$609B
$16.3M 5.21%
98,000
+20,000
+26% +$3.13M
GILD icon
7
Gilead Sciences
GILD
$167B
$15.7M 5.02%
140,000
-57,500
-29% -$5.93M
CVS icon
8
CVS Health
CVS
$137B
$13.7M 4.38%
202,000
-15,000
-7% -$898K
ZBH icon
9
Zimmer Biomet
ZBH
$17.6B
$12.9M 4.12%
113,631
-24,083
-17% -$2.58M
ELV icon
10
Elevance Health
ELV
$80.9B
$12.5M 4.01%
28,779
+11,500
+67% +$4.62M
CAH icon
11
Cardinal Health
CAH
$53.5B
$12.1M 3.88%
88,000
– –
CNC icon
12
Centene
CNC
$32.8B
$10.7M 3.44%
177,000
+7,000
+4% +$423K
BMRN icon
13
BioMarin Pharmaceuticals
BMRN
$11.5B
$9.71M 3.11%
137,348
-80,000
-37% -$5.38M
INCY icon
14
Incyte
INCY
$23.4B
$9.63M 3.08%
159,000
-38,400
-19% -$2.68M
EW icon
15
Edwards Lifesciences
EW
$49.4B
$8.92M 2.86%
123,000
+24,000
+24% +$1.72M
BRKR icon
16
Bruker
BRKR
$8.86B
$8.85M 2.83%
211,970
+53,000
+33% +$2.76M
IONS icon
17
Ionis Pharmaceuticals
IONS
$8.99B
$8.62M 2.76%
285,842
+50,000
+21% +$1.64M
BAX icon
18
Baxter International
BAX
$11.7B
$8.48M 2.72%
247,650
+89,000
+56% +$2.91M
QGEN icon
19
Qiagen
QGEN
$8.49B
$7.51M 2.4%
187,000
-11,327
-6% -$476K
HUM icon
20
Humana
HUM
$48B
$6.62M 2.12%
25,000
+11,000
+79% +$2.97M
THC icon
21
Tenet Healthcare
THC
$16.8B
$5.78M 1.85%
43,000
+21,000
+95% +$2.77M
ELAN icon
22
Elanco Animal Health
ELAN
$12.9B
$5.01M 1.6%
477,073
+200,166
+72% +$2.26M
GEHC icon
23
GE HealthCare
GEHC
$28.7B
$5M 1.6%
62,000
+12,000
+24% +$1.03M
PTCT icon
24
PTC Therapeutics
PTCT
$6.52B
$4.7M 1.51%
92,250
+27,000
+41% +$1.35M
TNDM icon
25
Tandem Diabetes Care
TNDM
$1.17B
$3.46M 1.11%
+180,523
New +$5.28M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2025 Portfolio in Review

As of Q1 2025, Sector Gamma AS held 35 positions worth $312M, up 7.3% from $291M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sector Gamma AS's Q1 2025 filing shows 5 new, 15 increased, 12 reduced and 2 closed positions. Its largest new stake was Tandem Diabetes Care: 180,523 shares worth $3.46M. The largest sale was Medtronic, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

  • Sector Gamma AS's largest Q1 2025 buy was Tandem Diabetes Care: 180,523 shares worth $3.46M.
  • Sector Gamma AS added most to Elevance Health in Q1 2025, an estimated $4.62M increase.
  • Sector Gamma AS's biggest Q1 2025 reduction was Medtronic, cutting an estimated $10.3M.
  • Sector Gamma AS fully exited Legend Biotech in Q1 2025, selling an estimated $1.58M.
  • Sector Gamma AS's ten largest holdings make up 57% of its $312M portfolio in Q1 2025.
  • Sector Gamma AS opened 5 new positions and closed 2 in Q1 2025.
  • Sector Gamma AS's portfolio value rose 7.3% quarter-over-quarter to $312M.

Based on Sector Gamma AS's 13F filing for Q1 2025, filed 13 May 2025.